Skip to main content
Have a personal or library account? Click to login
Trends in Pancreatic Cancer Mortality in Serbia: A Joinpoint Regression Analysis Cover

Figures & Tables

Table 1.

Number of death cases, crude rates and ASRs (per 100,000) for pancreatic cancer in Serbia, 2000 – 2021.

YearTotalMenWomen
NCrude rateASRaNCrude rateASRaNCrude rateASRa
20007479.945.3040110.976.483468.964.28
200177210.295.3444512.207.043278.483.96
200283511.135.7246612.787.223699.584.49
200385511.435.8745112.406.9840410.514.88
200485211.425.7047613.127.323769.814.29
200598813.326.6151814.328.074706.253.11
200691012.286.1152014.437.9939010.244.54
200796613.096.1849113.687.4247512.525.13
2008103414.076.6056115.708.2947312.535.17
2009102013.036.4954615.348.1947412.605.01
2010108814.927.0656615.969.5152213.945.78
2011105514.586.7357016.188.3248513.065.43
2012109915.266.6557316.348.0452614.245.46
2013107014.936.5658516.768.2448513.195.12
2014105614.816.4157316.507.9948313.205.09
2015113415.986.8961817.898.4451614.185.61
2016115116.316.8359917.428.1555215.255.81
2017115616.476.7761918.108.3553714.915.44
2018116816.736.9861518.088.4155315.445.79
2019120617.367.1464018.918.6956615.895.80
2020116916.946.8162518.608.4654415.375.39
2021115716.936.7659517.887.9756216.025.74
Overall2248814.156.431205315.628.241043512.555.06
Figure 1.

Trends of age-standardized pancreatic cancer mortality rates in Serbia by sex, in the period 2000–2021.

Figure 2.

Distribution of pancreatic cancer mortality by age groups in Serbia, 2000 – 2021.

Figure 3.

Trend in mortality of pancreatic cancer in Serbia, 2000 – 2021.

Table 2.

Joinpoint regression analysis* of pancreatic cancer mortality by age in Serbia, 2000 – 2021.

TotalMenWomen
ASR±SDAAPCa (95% CIb)ASR±SDAAPCa (95% CIb)ASR±SDAAPCa (95% CIb)
25 – 290.2±0.20.1±0.20.2±0.3
30 – 340.3±0.30.3±0.40.3±0.5
35 – 390.4±0.4−0.9 (−4.5–2.9)1.2±0.70.3±0.5
40 – 442.1±0.6−1.3 (−3.6–1.2)3.1±1.5−1.5 (−4.3–1.5)1.4±0.7
45 – 495.01±1.20.4 (−1.4–2.4)6.3±2.0−0.5 (−2.5–1.6)3.9±1.82.1 (−2.4–7.1)
50 – 5410.4±1.20.1 (−0.8–0.9)13.8±4.2−0.1 (−1.9–1.7)7.8±1.50.5 (−1.2–2.3)
55 – 5918.7±2.10.1 (−0.8–1.1)24.5±3.9−0.7 (−1.9–0.5)13.3±2.41.9* (0.6–3.2)
60 – 6427.8±3.01.2* (0.5–1.8)35.2±5.11.1* (0.1–2.2)20.7±4.11.7 (−0.2–3.7)
65 – 6940.0±5.51.7* (1.1–2.4)50.6±7.41.* (1.0–2.5)30.2±5.82.1* (0.6–3.7)
70 – 7452.2±6.11.6* (0.6–2.6)63.5±9.81.6* (0.6–2.6)42.9±6.60.9* (0.01–1.8)
75 – 7962.1±9.42.5* (1.2–3.7)71.3±14.52.1* (0.6–3.6)53.7±9.02.9* (0.3–3.6)
80 – 8470.4±10.01.7* (0.7–2.8)77.9±18.11.5 (−1.1–4.3)65.2±12.22.1* (0.7–3.4)
85+63.3±11.43.1* (1.6–4.5)68.2±22.957.9±13.34.4* (2.1–6.4)

a AAPC – Average Annual Percent Change

b CI – Confidence Interval

* Statistically significant trend

DOI: https://doi.org/10.2478/eabr-2025-0007 | Journal eISSN: 2956-2090 (formerly 2335-075X, 2956-0454) | Journal ISSN: 2956-0454 (formerly 1820-8665)
Language: English
Page range: 353 - 360
Submitted on: Apr 4, 2025
Accepted on: May 8, 2025
Published on: Aug 7, 2025
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services

© 2025 Sanja Ilic, Filip Dzudovic, Jovana Radovanovic, Viktor Selakovic, Emilija Subanovic, Natalija Djurovic, Dragana Andric, Zorana Babic, Svetlana Vukosavljevic, Maja Mirocevic Rotolo, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.